18:50:32 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-11-05 15-10 2024-Q3
2024-08-26 Kvartalsrapport 2024-Q2
2024-05-07 15-10 2024-Q1
2024-03-15 Ordinarie utdelning NNIT 0.00 DKK
2024-03-14 Årsstämma 2024
2024-02-20 Bokslutskommuniké 2023
2023-11-09 15-10 2023-Q3
2023-08-31 Kvartalsrapport 2023-Q2
2023-05-05 15-10 2023-Q1
2023-04-18 Ordinarie utdelning NNIT 0.00 DKK
2023-04-17 Årsstämma 2023
2023-03-23 Bokslutskommuniké 2022
2022-11-02 Kvartalsrapport 2022-Q3
2022-08-12 Kvartalsrapport 2022-Q2
2022-05-06 Kvartalsrapport 2022-Q1
2022-03-11 Ordinarie utdelning NNIT 0.00 DKK
2022-03-10 Årsstämma 2022
2022-01-28 Bokslutskommuniké 2021
2021-11-03 Kvartalsrapport 2021-Q3
2021-08-20 Halvårsutdelning NNIT 0
2021-08-12 Kvartalsrapport 2021-Q2
2021-05-07 Kvartalsrapport 2021-Q1
2021-03-11 Halvårsutdelning NNIT 1
2021-03-10 Årsstämma 2021
2021-01-29 Bokslutskommuniké 2020
2020-10-29 Kvartalsrapport 2020-Q3
2020-08-17 Halvårsutdelning NNIT 2
2020-08-13 Kvartalsrapport 2020-Q2
2020-05-06 Kvartalsrapport 2020-Q1
2020-03-06 Halvårsutdelning NNIT 2
2020-03-05 Årsstämma 2020
2020-01-29 Bokslutskommuniké 2019
2019-10-24 Kvartalsrapport 2019-Q3
2019-08-19 Halvårsutdelning NNIT 2
2019-08-14 Kvartalsrapport 2019-Q2
2019-05-14 Kvartalsrapport 2019-Q1
2019-03-08 Halvårsutdelning NNIT 2.6
2019-03-07 Årsstämma 2019
2019-01-30 Bokslutskommuniké 2018
2018-10-25 Kvartalsrapport 2018-Q3
2018-08-22 Halvårsutdelning NNIT 2
2018-08-17 Kvartalsrapport 2018-Q2
2018-05-16 Kvartalsrapport 2018-Q1
2018-03-09 Halvårsutdelning NNIT 2.3
2018-03-08 Årsstämma 2018
2018-01-25 Bokslutskommuniké 2017
2017-10-26 Kvartalsrapport 2017-Q3
2017-08-21 Halvårsutdelning NNIT 2
2017-08-16 Kvartalsrapport 2017-Q2
2017-05-18 Kvartalsrapport 2017-Q1
2017-03-09 Halvårsutdelning NNIT 2.2
2017-03-08 Årsstämma 2017
2017-03-08 Extra Bolagsstämma 2017
2017-01-25 Bokslutskommuniké 2016
2016-10-26 Kvartalsrapport 2016-Q3
2016-08-22 Halvårsutdelning NNIT 2
2016-08-16 Kvartalsrapport 2016-Q2
2016-05-13 Kvartalsrapport 2016-Q1
2016-03-14 Halvårsutdelning NNIT 4
2016-03-11 Årsstämma 2016
2016-01-27 Bokslutskommuniké 2015
2015-11-17 Kvartalsrapport 2015-Q3
2015-08-21 Kvartalsrapport 2015-Q2
2015-05-12 Kvartalsrapport 2015-Q1
2015-02-09 Bokslutskommuniké 2014

Beskrivning

LandDanmark
ListaMid Cap Copenhagen
SektorTjänster
IndustriIT-konsult & onlinetjänster
NNIT är ett IT-bolag. Bolaget tillhandahåller lösningar inom design och implementation av IT-lösningar till läkemedelsindustrin men även för kunder inom finans och offentlig sektor. Mjukvaruutveckling och affärsprocesser är en del i utbudet som kompletteras med teknisk rådgivning och support. Verksamhet bedrivs på global nivå med störst verksamhet inom Europa, Nordamerika och Asien. NNIT grundades 1994 och huvudkontoret är beläget i Söborg, Danmark.
2019-01-29 19:07:06

Financial report 2018 and Annual General Meeting 2019  

Full year revenue growth of 5.5% and an operating profit margin of 10.2%  

Performance highlights for full year 2018:

  • Revenue from clients outside the Novo Nordisk Group increased by 13% driven by the international life sciences, public and enterprise customer groups all increasing double-digit
  • Due to a decline in revenue from the Novo Nordisk Group of 5.2% total revenue increased by 5.5% in reported currencies
  • The share of revenue clients outside the Novo Nordisk Group increased from 58% in 2017 to 63% in 2018
  • Operating profit increased by 17% leading to an operating profit margin of 10.2% in reported currencies compared to 9.2% in 2017
  • Net profit of DKK 236m in 2018 compared to DKK 199m in 2017
  • Free cash flow after acquisitions in 2018 was DKK 116m compared to negative DKK 13m in 2017
  • Order backlog for 2019 at the beginning of Q1 2019 was DKK 2,171m, a decrease of 1.9% compared to the same time last year. The backlog for 2020-2021 increased by 3.5%
  • Outlook for 2019: 
    • Revenue growth of 3-6% in constant currencies
    • Operating profit margin of 10-10.5% in constant currencies
    • Level of investments is 5-7% of total revenue
  • New strategy and long-term targets
    • Organic revenue growth of 6-8% excluding revenue from the Novo Nordisk Group
    • Operating profit margin of at least 10% is maintained
  • The Board of Directors proposes to increase the dividend payments to DKK 4.60 per share corresponding to DKK 113.0m which includes the interim dividend for 2018 (DKK 49.1m) paid in August 2018. This corresponds to a pay-out ratio of net profit of 48%

Per Kogut, CEO at NNIT comments: “I am pleased that the strong growth continued in Q4 securing full year revenue growth of 5.5% and an operating profit margin of 10.2% in line with our guidance. This strong performance was driven by double-digit growth from international life sciences, enterprise and public customer groups offsetting lower sales to the Novo Nordisk Group. We are launching a new strategy and a more customer focused organization to enable further innovation and digital transformation for our clients while accelerating our growth within international life sciences and Danish clients.”  

Conference call details

NNIT will host a teleconference January 30, 2019 at 10:30 CET about the financial report for 2018. Please visit the NNIT webpage at www.nnit.com to access the teleconference, which can be found under ‘Investors – Events & presentations’. Presentation material will be available on the website approximately one hour prior to the start of the presentation. 

Conference call details

https://nnit.eventcdn.net/20190130 

Participant telephone numbers:

Denmark:                     +45 3544 5583

United Kingdom:           +44 20 3194 0544

Sweden:                       +46 8 5664 2661

United States:               +1 855 269 2604  

Financial Calendar 2019

March 7, 2019              Annual General Meeting

March 8, 2019              Dividend ex dividend date

March 11, 2019            Dividend record date

March 12, 2019            Dividend payment date

May 14, 2019               Interim report for the first three months of 2019

August 14, 2019           Interim report for the first six months of 2019

October 24, 2019          Interim report for the first nine months of 2019  

Annual General Meeting

The Annual General Meeting of NNIT A/S will be held on Thursday March 7, 2019 at 2 pm at the NNIT head office, Oestmarken 3A, 2860 Soeborg, Denmark.   

The Board of Directors intends to propose re-election of Anne Broeng, Carsten Dilling, Eivind Kolding, Peter Haahr, Caroline Serfass and Christian Kanstrup. The Board of Directors also intends to propose re-election of Carsten Dilling as Chairman and re-election of Peter Haahr as Deputy Chairman.  

The Board of Directors intends to propose re-election of PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab as the Company’s auditor. 

Proposed dividend

Due to the strong underlying cash flow generation, the Board of Directors intends to propose to the shareholders at the annual general meeting that dividends of DKK 2.60 per share be distributed for the financial year 2018. Including the interim dividend of DKK 2.00 per share in August 2018 this brings the total dividend for the financial year 2018 to DKK 4.60 per share (2017: DKK 4.30 per share), equal to a dividend pay-out ratio of 48% of the 2018 net results.
  

Contacts for further information

Investor relations:             

Klaus Hosbond Skovrup                         

Head of Investor Relations                     

Tel: +45 3079 5355                              

ksko@nnit.com                                                

  

Media relations:

Helga Heyn

NNIT Communications

Tel: +45 3077 8141

hhey@nnit.com


About NNIT

NNIT A/S is one of Denmark’s leading IT service providers and consultancies. NNIT A/S offers a wide range of IT services and solutions to its customers, primarily in the life sciences sector in Denmark and internationally and to customers in the public, enterprise and finance sectors in Denmark. As of December 31, 2018 NNIT A/S had 3,214 employees. NNIT has approximately 400 clients of which around 150 are located outside Denmark. Some 20% are international life sciences clients (December, 2018). For more information please visit www.nnit.com.


Attachment